Obstructive nephropathy secondary to sulfasalazine calculi

Urology

Volumn 62, Issue 4, 2003, Pages 748-

  Russinko, Paul J ^a   Agarwal, Saraub ^a   Choi, Michael J ^a   Kelty, Patrick J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE POTASSIUM; DRUG METABOLITE; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYSTOSCOPY; FEMALE; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LITHOTOMY; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PYELONEPHRITIS; RETROGRADE PYELOGRAPHY; STONE ANALYSIS; ULCERATIVE COLITIS; URETER STENT; URETER STONE; UROLITHIASIS;

EID: 0141784050     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00666-6     Document Type: Article

References (5)

1. Hess B. Drug-induced urolithiasis. Curr Opin Urol. 8:1998;331.
2. McLeod R.S., Churchill D.N. Urolithiasis complicating inflammatory bowel disease. J Urol. 148:1992;974.
3. Tanigawara YT, Yusuke TK, Aoyama N, et al: N-acetyltransferase 2 genotype-related sulfapyridine acetylatine and its adverse events. Biol Pharm Bull 25: 1058, 2002.
4. Erturk E., Casemento J.B., Guertin K.R., et al. Bilateral acetylsulfapyridine nephrolithiasis associated with chronic sulfasalazine therapy. J Urol. 151:1994;1605.
5. Hein R, Brunkhorst R, Thon WF, et al: Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases. Clin Nephrol 39: 254, 1993.